<?xml version="1.0" encoding="UTF-8"?>
<ref id="B136-viruses-12-00276">
 <label>136.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Lazar</surname>
    <given-names>G.A.</given-names>
   </name>
   <name>
    <surname>Dang</surname>
    <given-names>W.</given-names>
   </name>
   <name>
    <surname>Karki</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Vafa</surname>
    <given-names>O.</given-names>
   </name>
   <name>
    <surname>Peng</surname>
    <given-names>J.S.</given-names>
   </name>
   <name>
    <surname>Hyun</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Chan</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Chung</surname>
    <given-names>H.S.</given-names>
   </name>
   <name>
    <surname>Eivazi</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Yoder</surname>
    <given-names>S.C.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Engineered antibody Fc variants with enhanced effector function</article-title>
  <source>Proc. Natl. Acad. Sci. USA</source>
  <year>2006</year>
  <volume>103</volume>
  <fpage>4005</fpage>
  <lpage>4010</lpage>
  <pub-id pub-id-type="doi">10.1073/pnas.0508123103</pub-id>
  <pub-id pub-id-type="pmid">16537476</pub-id>
 </element-citation>
</ref>
